- News Releases
-
- Sep. 30, 2020 (PDF/98KB)R&D
- Myovant Sciences Announces Results of Additional Secondary Endpoint of Castration Resistance-Free Survival from Phase 3 HERO Study of Relugolix in Advanced Prostate Cancer
-
- Sep. 23, 2020 (PDF/98KB)Corporate
- Sumitomo Dainippon Pharma Establishes a Subsidiary in Taiwan
-
- Sep. 18, 2020 (PDF/542KB)Others
- Sumitomo Dainippon Pharma and KDDI Announce Start of Initiatives to Create New Platform for Communication between MRs and HealthCare Professionals Using XR
-
- Sep. 17, 2020 (PDF/80KB)Corporate
- Sumitomo Dainippon Pharma Announces Change in Executive Officer
Other Notices
-
- Sep. 30, 2020Others
- Posted Integrated Report 2020
-
- Jun. 30, 2020Others
- Posted Factbook 2020
IR Library
-
Aiming to create innovative pharmaceutical products
-
Targeting sustainable growth
-
Leading our global expansion